Sedentary Lifestyles Drive The Anti-Hypertensive Drugs Industry


Anti-Hypertensive Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030

The Business Research Company’s Anti-Hypertensive Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030

LONDON, GREATER LONDON, UK, May 5, 2021 / — According to anti-hypertensive drugs market research, sedentary lifestyles are a major driver for the growth of the market. Consumption of junk food, lack of proper healthy and balanced diet, lack of proper sleep due to irregular work shifts have contributed to the increase in hypertension. Hypertension is the underlying factor for at least 45% of deaths due to heart disease and 51% of deaths due to stroke. Once the patient is diagnosed with hypertension, patients are required to use the drugs to control hypertension based on the severity of the condition. This creates a sustainable demand for the product and acts as a prominent driver for the growth of the market.

The anti-hypertensive drugs market consists of sales of anti-hypertensive drugs and related services. These drugs are re used to prevent heart failure, kidney failure and acute stroke induced by hypertension. Some of the major anti-hypertensive drugs include diuretics, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin II receptor antagonists.

Read More On The Global Anti-Hypertensive Drugs Market Report:

The global anti-hypertensive drugs market size is expected to grow from $24.17 billion in 2020 to $24.37 billion in 2021 at a compound annual growth rate (CAGR) of 0.8%. The slow growth is mainly due to the outbreak of COVID-19 as hypertensive drugs have a negative effect on COVID-19 patients. The anti-hypertensive drugs market is expected to reach $27.81 billion in 2025 at a CAGR of 3.4%.

Major players in the anti-hypertensive drugs market are Merck & Co. Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited, Johnson & Johnson Ltd., Pfizer Inc., Novartis AG, Sanofi SA, United Therapeutics, Ranbaxy Laboratories, Bayer AG, Lupin Limited, Boehringer Engelheim GmbH, and Bayer AG.

The market covered in the anti-hypertensive drugs market report is segmented by therapeutics into diuretics, angiotensin receptor blockers (ARBs), angiotensin converting enzyme (ACE) inhibitors, beta blockers, alpha blockers, calcium channel blockers, renin inhibitors, vasodilators; by disease source into primary hypertension, secondary hypertension; by end users into hospitals, clinics, homecare.

Anti-Hypertensive Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030 is one of a series of new reports from The Business Research Company that provides anti-hypertensive drugs market overview, forecast anti-hypertensive drugs market size and growth for the whole market, anti-hypertensive drugs market segments, and geographies, anti-hypertensive drugs market trends, anti-hypertensive drugs market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global AntiHypertensive Drugs Market Report:

Here Is A List Of Similar Reports By The Business Research Company:
Cardiovascular Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030

Wearable Blood Pressure Monitors Market – By Product (Upper Arm Blood Pressure Monitor, Wrist Blood Pressure Monitor, Finger Blood Pressure Monitor), And By Region, Opportunities And Strategies – Global Forecast To 2030

Pharmaceuticals Market – By Type (Pharmaceutical Drugs, Biologics), By Type Of Pharmaceutical Drugs (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs), By Type Of Biologics Drugs (Monoclonal Antibodies (MAbs), Therapeutic Proteins, Vaccines), And By Region, Opportunities And Strategies – Global Forecast To 2030

Interested to know more about The Business Research Company?
Read more about us at

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
Visit us on social media: